
Pharma Pulse 5/21/24: Hims & Hers Announces Access to GLP-1 Injections, The Impact of the Presidential Election on Pharma & more
The latest news for pharma industry insiders.
Experts discuss how the upcoming election is impacting the pharma industry, and how either party’s victory could change the landscape in the following years.
Despite the finding, the authors suggest further research is done to better understand the mechanisms behind the interactions between asthma, sleep, and depression.
Brain-chip startup has proposed solutions for thread pullout problem experienced by first participant, Noland Arbaugh
Hims & Hers unlocks access to injectable GLP-1 medications, expanding its holistic weight loss program focused on personalized and affordable solutions; prices start as low as $199 a month
Supply chain risk mitigation: A conversation with Nick Porter, President of World Courier.
Join Nick as he discusses key industry trends with Nicholas Saraceno Editor, Pharmaceutical Commerce Magazine, at LogiPharma Europe 2024.
This thoughtful Q&A explores the growing importance and use of real-time monitoring and digital tools for managing supply chain risks. Nick shares his perspectives on the role of artificial intelligence in shaping pharma logistics' future. From using technology to increase supply chain visibility to meeting specific demands of cold-chain storage for cell and gene therapies, Nick also provides an overview of pharmaceutical logistics' evolving landscape.
This interview is essential reading for anyone keen to understand how innovative approaches and data-driven strategies can streamline supply chains and advance sustainability objectives.
Watch the full video interview here: https://lnkd.in/gnwem-Fc
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

